Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
107 hedge funds and large institutions have $38.5M invested in Zomedica Corp. in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 20 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 26
0% more funds holding
Funds holding: 107 → 107 (0)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
39% less capital invested
Capital invested by funds: $63M → $38.5M (-$24.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$2.67M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$539K |
| 3 |
VF
Virtu Financial
New York
|
+$505K |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$478K |
| 5 |
UBS AM
Chicago,
Illinois
|
+$387K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.43M |
| 2 |
HF
HRT Financial
New York
|
-$209K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$209K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$177K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$176K |
ZOM Hedge Fund Activity: Q4 2021 in Review
107 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2021, worth a combined $38.5M — down 39% from $63M a quarter earlier.
Fund positioning in ZOM was balanced in Q4 2021: 20 funds opened new positions, 20 closed out, 32 added to existing stakes and 26 trimmed.
The largest buyer was State Street, adding an estimated $2.67M. The largest seller was BlackRock, cutting an estimated $2.43M.
- 107 institutional investors held Zomedica Corp. (ZOM) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $38.5M of Zomedica Corp. stock for Q4 2021, down 39% quarter-over-quarter.
- 20 funds opened new Zomedica Corp. positions in Q4 2021 and 20 closed out, a net change of 0 holders.
- The largest Zomedica Corp. buyer in Q4 2021 was State Street, an estimated $2.67M added.
- The largest Zomedica Corp. seller in Q4 2021 was BlackRock, an estimated $2.43M sold.
Based on aggregated 13F filings for Q4 2021.